Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha

被引:23
|
作者
Li, Guolin [1 ,2 ,3 ]
Brocker, Chad N. [1 ]
Yan, Tingting [1 ]
Xie, Cen [1 ]
Krausz, Kristopher W. [1 ]
Xiang, Rong [4 ,5 ]
Gonzalez, Frank J. [1 ]
机构
[1] NCI, Lab Metab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] Hunan Normal Univ, Coll Life Sci, Lab Aging Biochem, Changsha 410081, Hunan, Peoples R China
[3] Hunan Normal Univ, Coll Life Sci, Minist Educ, Key Lab Prot Chem & Dev Biol, Changsha 410081, Hunan, Peoples R China
[4] Cent S Univ, State Key Lab Med Genet, Changsha 41001, Hunan, Peoples R China
[5] Cent S Univ, Sch Life Sci, Changsha 41001, Hunan, Peoples R China
来源
MOLECULAR METABOLISM | 2018年 / 7卷
基金
美国国家卫生研究院;
关键词
PPARA; PPARalpha; Intermittent fasting; Every-other-day fasting; Steatosis; Adaptive fasting response; FATTY-ACID OXIDATION; PPAR-ALPHA; HEPATIC STEATOSIS; LIVER-DISEASE; LIPID-METABOLISM; MICE; PHYSIOLOGY; MOUSE; MODEL; OBESITY;
D O I
10.1016/j.molmet.2017.10.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Peroxisome proliferator-activated receptor alpha (PPARA) is a major regulator of fatty acid oxidation and severe hepatic steatosis occurs during acute fasting in Ppara-null mice. Thus, PPARA is considered an important mediator of the fasting response; however, its role in other fasting regiments such as every-other-day fasting (EODF) has not been investigated. Methods: Mice were pre-conditioned using either a diet containing the potent PPARA agonist Wy-14643 or an EODF regimen prior to acute fasting. Ppara-null mice were used to assess the contribution of PPARA activation during the metabolic response to EODF. Livers were collected for histological, biochemical, qRT-PCR, and Western blot analysis. Results: Acute fasting activated PPARA and led to steatosis, whereas EODF protected against fasting-induced hepatic steatosis without affecting PPARA signaling. In contrast, pretreatment with Wy-14,643 did activate PPARA signaling but did not ameliorate acute fasting-induced steatosis and unexpectedly promoted liver injury. Ppara ablation exacerbated acute fasting-induced hypoglycemia, hepatic steatosis, and liver injury in mice, whereas these detrimental effects were absent in response to EODF, which promoted PPARA-independent fatty acid metabolism and normalized serum lipids. Conclusions: These findings indicate that PPARA activation prior to acute fasting cannot ameliorate fasting-induced hepatic steatosis, whereas EODF induced metabolic adaptations to protect against fasting-induced steatosis without altering PPARA signaling. Therefore, PPARA activation does not mediate the metabolic adaptation to fasting, at least in preventing acute fasting-induced steatosis. Published by Elsevier GmbH.
引用
收藏
页码:80 / 89
页数:10
相关论文
共 50 条
  • [1] Adaptation of peroxisome proliferator-activated receptor alpha to hibernation in bats
    Han, Yijie
    Zheng, Guantao
    Yang, Tianxiao
    Zhang, Shuyi
    Dong, Dong
    Pan, Yi-Hsuan
    BMC EVOLUTIONARY BIOLOGY, 2015, 15
  • [2] Hepatic peroxisome proliferator-activated receptor alpha mediates the major metabolic effects of Wy-14643
    Li, Guolin
    Brocker, Chad N.
    Xie, Cen
    Yan, Tingting
    Noguchi, Audrey
    Krausz, Kristopher W.
    Xiang, Rong
    Gonzalez, Frank J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (05) : 1138 - 1145
  • [3] Role of peroxisome proliferator-activated receptor-α in fasting-mediated oxidative stress
    Abdelmegeed, Mohamed A.
    Moon, Kwan-Hoon
    Hardwick, James P.
    Gonzalez, Frank J.
    Song, Byoung-Joon
    FREE RADICAL BIOLOGY AND MEDICINE, 2009, 47 (06) : 767 - 778
  • [4] Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process
    Lee, Joon No
    Dutta, Raghbendra Kumar
    Kim, Seul-Gi
    Lim, Jae-Young
    Kim, Se-Jin
    Choe, Seong-Kyu
    Yoo, Kyeong-Won
    Song, Seung Ryel
    Park, Do-Sim
    So, Hong-Seob
    Park, Raekil
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 442 (1-2) : 22 - 27
  • [5] Peroxisome proliferator-activated receptor alpha and the ketogenic diet
    Cullingford, Tim
    EPILEPSIA, 2008, 49 : 70 - 72
  • [6] Peroxisomal β-oxidation and peroxisome proliferator-activated receptor α:: An adaptive metabolic system
    Reddy, JK
    Hashimoto, T
    ANNUAL REVIEW OF NUTRITION, 2001, 21 : 193 - 230
  • [7] Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice
    Yang, Q
    Xie, Y
    Alexson, SEH
    Nelson, BD
    DePierre, JW
    BIOCHEMICAL PHARMACOLOGY, 2002, 63 (10) : 1893 - 1900
  • [8] Peroxisome proliferator-activated receptor α target genes
    Mandard, S
    Müller, M
    Kersten, S
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (04) : 393 - 416
  • [9] Divergence between human and murine peroxisome proliferator-activated receptor alpha ligand specificities
    Oswal, Dhawal P.
    Balanarasimha, Madhumitha
    Loyer, Jeannette K.
    Bedi, Shimpi
    Soman, Frances L.
    Rider, S. Dean, Jr.
    Hostetler, Heather A.
    JOURNAL OF LIPID RESEARCH, 2013, 54 (09) : 2354 - 2365
  • [10] Peroxisome Proliferator-Activated Receptor Targets for the Treatment of Metabolic Diseases
    Monsalve, Francisco A.
    Pyarasani, Radha D.
    Delgado-Lopez, Fernando
    Moore-Carrasco, Rodrigo
    MEDIATORS OF INFLAMMATION, 2013, 2013